Home>>Signaling Pathways>> Metabolism>> Ferroptosis>>Liproxstatin-1

Liproxstatin-1 Sale

Catalog No.GC15681

Liproxstatin-1 is a potent inhibitor of ferroptosis and can protect against ferroptosis-inducing agents, such as buthionine sulfoxamine (BSO), erastin, and (1S,3R)-RSL3 (RSL3).

Products are for research use only. Not for human use. We do not sell to patients.

Liproxstatin-1 Chemical Structure

Cas No.: 950455-15-9

Size Price Stock Qty
10mM (in 1mL DMSO)
$65.00
In stock
5mg
$67.00
In stock
25mg
$252.00
In stock
100mg
$493.00
In stock
500mg
$1,545.00
In stock
1g
$2,421.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 5 publications

Description Protocol Chemical Properties Product Documents Related Video Related Products

Liproxstatin-1 is a potent inhibitor of ferroptosis and can protect against ferroptosis-inducing agents, such as buthionine sulfoxamine (BSO), erastin, and (1S,3R)-RSL3 (RSL3). Moreover, Liproxstatin-1 does not interfere with other classical types of cell death, such as TNFα-induced apoptosis and H2O2-induced necrosis. Recently, Liproxstatin-1 has attracted the attentions as it exhibits various kinds of pharmacological activities. For example, Liproxstatin-1 can protect mouse myocardium against ischemia/reperfusion injury; Liproxstatin-1 could alleviate iron overload and attenuates morphine tolerance; Liproxstatin-1 could prevent both RSL3-induced death of primary human renal proximal TECs and GPX4 deletion-induced acute renal failure. Therefore, Liproxstatin-1 inhibits ferroptosis and promotes cell survival.[1].

The in vitro experiment demonstrated that Liproxstatin-1 could suppress ferroptosis, with an EC50 of 115.3 nM. The percentage of PI-positive cells was lower in the Liproxstatin-1 group further proving the anti-ferroptotic effect of Liproxstatin-1 (P < 0.0001). Furthermore, Liproxstatin-1 suppressed mitochondrial lipid peroxidation and increased the levels of GSH compared with the RSL-3 group (P < 0.0001). GPX4 was restored to normal levels by Liproxstatin-1 treatment.[2].

The in vivo experiment indicated that ferroptosis occurred in TECs during UUO-induced renal fibrosis and that Liproxstatin-1 was able to inhibit the ferroptosis. In addition, Liproxstatin-1 was able to prevent the morphological changes and renal function impairment that were induced by UUO in vivo.[1].

References:
[1] Zhang B, et al. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death Dis. 2021 Sep 11;12(9):843.
[2] Fan BY, et al. Liproxstatin-1 is an effective inhibitor of oligodendrocyte ferroptosis induced by inhibition of glutathione peroxidase 4. Neural Regen Res. 2021 Mar;16(3):561-566.

Reviews

Review for Liproxstatin-1

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Liproxstatin-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.